Not applicableUnknownNCT04142463What this trial is testingCollaborative Network to Take Responsibility for Oral Anticancer Therapy 2Who this might be right forOncologic Disorders Ilyse Kenis 500
Not applicableLooking for participantsNCT06317389What this trial is testingPACOME (PAtient Cancer Oral MEdication) Cohort of Patients Treated With Oral Anticancer Drugs Benefiting From Oncoral Multidisciplinary Monitoring in Real Life: Predictive Factors and Safety of TreatmentsWho this might be right forCancerOncologyOncoral Program Hospices Civils de Lyon 3,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT05548127What this trial is testingTACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)Who this might be right forBreast Cancer Pfizer 37
Not applicableLooking for participantsNCT03257969What this trial is testingImpact of the DROP Program on the DRP (Drug Related Problems) Related to Oral Anticancer Drugs in Ambulatory Patients with Risk FactorsWho this might be right forCancer Hospices Civils de Lyon 248
Not applicableLooking for participantsNCT03296150What this trial is testingADOPT-PRESTAGE: Study Evaluating the Impact of the Program PRESTAGEWho this might be right forCancerOral Anticancer Drugs Hospices Civils de Lyon 139
Not applicableStudy completedNCT02833246What this trial is testingUsing a Patient-Centered mHealth Intervention to Improve Adherence to Oral Anticancer MedicationsWho this might be right forSarcomaLungSolid Tumor Gastrointestinal Memorial Sloan Kettering Cancer Center 28
Not applicableLooking for participantsNCT04797143What this trial is testingImpact of a Multidisciplinary Consultation Program on Drug Adherence in First Oral Anticancer TreatmentWho this might be right forMultidisciplinary Consultation ProgramAdherence to Oral Anticancer TreatmentDrug Related Toxicity+1 more Centre Hospitalier Universitaire, Amiens 300
Not applicableUnknownNCT03660670What this trial is testingMedico-economic Evaluation of the ONCORAL Program for Ambulatory Patients Under Oral Anticancer Drugs Versus Usual CareWho this might be right forCancer Hospices Civils de Lyon 215
Not applicableEnded earlyNCT04595851What this trial is testingPharmacists Coordinated Care Oncology Model (PCOM) for Patients Taking Oral Anti-cancer MedicationsWho this might be right forChronic Myeloid LeukemiaChronic Lymphocytic LeukemiaMultiple Chronic Conditions University of Michigan Rogel Cancer Center 6
Early research (Phase 1)Study completedNCT02908750What this trial is testingStudy to Assess the Effect of Osimertinib (TAGRISSO™ ) on Blood Levels of Fexofenadine in Patients With EGFRm+ NSCLCWho this might be right forNon Small Cell Lung Cancer AstraZeneca 24
Not applicableLooking for participantsNCT07073807What this trial is testingMobile Health Intervention to Improve Adherence to Oral Anticancer TherapyWho this might be right forCancerNeoplasms University of California, Irvine 35
Not applicableLooking for participantsNCT06566560What this trial is testingThe ROAD 2.0 to Sustainable Medication Use: Redispensing Unused Oral Anticancer DrugsWho this might be right forCancerOncologyPharmacy+1 more Radboud University Medical Center 2,500
Not applicableStudy completedNCT03952312What this trial is testingOncotool for Cancer MedicationsWho this might be right forCancerCancer, Treatment-RelatedMedication Adherence+2 more Northwestern University 83
Early research (Phase 1)Study completedNCT01900028What this trial is testingTo Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid TumoursWho this might be right forSolid Tumours AstraZeneca 85
Early research (Phase 1)Study completedNCT01921140What this trial is testingTo Determine the Effect of Food on the Pharmacokinetics of Olaparib and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation in Patients With Advanced Solid TumoursWho this might be right forSolid Tumours AstraZeneca 60
Early research (Phase 1)Study completedNCT02224053What this trial is testingDrug-Drug Interaction Study With AZD9291 and Omeprazole in Healthy VolunteersWho this might be right forHealthy Volunteer AstraZeneca 136
Early research (Phase 1)Study completedNCT02163733What this trial is testingStudy to Determine the Effect of Food on the Blood Levels of AZD9291 Following Oral Dosing of a Tablet Formulation in Patients With Non-Small Cell Lung CancerWho this might be right forAdvanced Non Small Cell Lung CancerAdvanced (Inoperable) Non Small Cell Lung Cancer AstraZeneca 38
Early research (Phase 1)Study completedNCT01929603What this trial is testingStudy to Assess the Effect of Rifampicin (CYP Inducer) on Blood Levels and Safety of Olaparib in Patients With Advanced Solid TumoursWho this might be right forSolid Tumours AstraZeneca 32
Not applicableLooking for participantsNCT04484064What this trial is testingOptimization of the Targeted Anticancer TherapiesWho this might be right forCancer Centre Hospitalier Universitaire Vaudois 500
Not applicableLooking for participantsNCT06726889What this trial is testingIncreasing Oral Medication Adherence for Metastatic Breast Cancer PatientsWho this might be right forBreast Cancer European Institute of Oncology 104